← Back to Prospects

Ascendis Pharma

StrongLikely has broker

Doubled to 22K SF, "well more than 100 employees" planned, but likely already has a broker

Company Info

Industry
Rare Endocrine Diseases / Biopharma
Location
Princeton, NJ
Employees
100+100.0%

Office Situation

Address
212 Carnegie Center Boulevard, Princeton, NJ (expanded Oct 2025)
Current Space
22,040 SF
Lease Expiry
Not found

Funding

Total Raised
Publicly traded (ASND, NASDAQ, ~$4B market cap)
Last Round
Public company
Round Date

Decision Makers

Jay Donovan WuPrimary3rd
EVP & President, US Market
Princeton, NJ
Joined Jan 2025. Previously VP & Head of Rare Diseases at Genentech (13 years). Stanford MBA, UPenn undergrad. Board member Egetis Therapeutics.

Qualification

Danish biopharma (NASDAQ: ASND, ~$4B mkt cap) that doubled Princeton footprint to 100+ people (Oct 2025). Plans for continued growth. Strong company in right location BUT high probability they already have a tenant rep from the Oct 2025 expansion. Worth soft relationship-building outreach for future growth beyond current space.

Broker Intel

Likely has broker

Moved from 902 Carnegie Center to 212 Carnegie Center Blvd (Oct 2025). 22K SF lease by public company almost certainly involved a tenant rep. JLL (Thomas Romano) markets 212 Carnegie Center. High probability of existing broker relationship.

Warm Intro Paths

Sources

ClaimSource
Doubled from 11,805 to 22,040 SF at 212 Carnegie Center (Oct 2025)NJ Business Magazine
Plans for "well more than 100 employees"NJ Business Magazine
Previous address: 902 Carnegie Center, Suite 301Patch
JLL markets 212 Carnegie CenterJLL listing
Jay Donovan Wu led ribbon cuttingNJ Business Magazine

Draft Outreach Message

Hi Jay — Congrats on the 212 Carnegie Center expansion and the incredible team growth! As Ascendis continues scaling past 100 employees in Princeton, I'd love to be a resource for your next phase of growth. I'm Carly Toth with Adam Englander at CBRE — we know Carnegie Center and the Route 1 corridor deeply. If you're planning further expansion or evaluating additional space, we'd love to help. — Carly